Methylation of TIMP3 in esophageal squamous cell carcinoma
Open Access
- 1 January 2008
- journal article
- Published by Baishideng Publishing Group Inc. in World Journal of Gastroenterology
- Vol. 14 (2) , 203-210
- https://doi.org/10.3748/wjg.14.203
Abstract
AIM: To measure the frequency of DNA methylation of the tissue inhibitor of metalloproteinase 3 (TIMP3) promoter and relate this to any change of gene expression in esophageal squamous cell carcinoma in patients from a region of high incidence in China. METHODS: Cancer cell lines were treated with or without the demethylating reagent 5-aza-2’-deoxycytidine. Methylation of the TIMP3 promoter was assessed in three regions by melt curve analysis and its expression was assessed by real-time RT-PCR. Tumors and proximal resection margins were obtained from 64 patients with esophageal squamous cell carcinoma from a region of high incidence in China. Methylation was assessed by melt curve analysis and expression by immunohistochemistry. RESULTS: Methylation in one of the three promoter regions assessed correlated with gene silencing in esophageal cell lines. A degree of methylation of TIMP3 was found in only four esophageal squamous cell carcinomas, and partial loss of TIMP3 protein expression in just one. CONCLUSION: Methylation and loss of expression of TIMP3 occurs infrequently in esophageal squamous cell carcinoma in a region of high incidence in China.Keywords
This publication has 39 references indexed in Scilit:
- Expression of tissue inhibitor of metalloproteinase‐3 (TIMP‐3) and its prognostic significance in resected non‐small cell lung cancerJournal of Surgical Oncology, 2007
- Tissue inhibitor of metalloproteinase-3 induces apoptosis in prostate cancer cells and confers increased sensitivity to paclitaxelEuropean Journal Of Cancer, 2006
- In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2Lung Cancer, 2006
- Matrix metalloproteinases and tumor metastasisCancer and Metastasis Reviews, 2006
- Prognostic relevance of uPAR-del4/5 and TIMP-3 mRNA expression levels in breast cancerEuropean Journal Of Cancer, 2005
- Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinomaEuropean Journal Of Cancer, 2005
- Aberrant CpG island methylation in early-onset sporadic gastric carcinomaZeitschrift für Krebsforschung und Klinische Onkologie, 2005
- Inactivation of p16, RUNX3, and HPP1 occurs early in Barrett's-associated neoplastic progression and predicts progression riskOncogene, 2005
- Tissue inhibitor of metalloproteinase‐3 (TIMP‐3) gene is methylated in the development of esophageal adenocarcinoma: Loss of expression correlates with poor prognosisInternational Journal of Cancer, 2005
- Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3Carcinogenesis: Integrative Cancer Research, 1996